Google Scholar: citations
AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells
Rafael, Diana (Universitat Autònoma de Barcelona)
Gener, Petra (Hospital Universitari Vall d'Hebron)
Andrade, Fernanda (Instituto de Salud Carlos III)
Seras-Franzoso, Joaquin (Hospital Universitari Vall d'Hebron)
Montero, Sara (Hospital Universitari Vall d'Hebron)
Fernández Caparrós, Yolanda (Hospital Universitari Vall d'Hebron)
Hidalgo, Manuel (Rosenberg Clinical Cancer Center Beth Israel Deaconess Medical Center)
Arango, Diego (Hospital Universitari Vall d'Hebron)
Florindo, Helena F. (Universidade de Lisboa)
Abasolo, Ibane (Hospital Universitari Vall d'Hebron)
Schwartz, Simon (Instituto de Salud Carlos III)
Videira, Mafalda (Universidade de Lisboa)
Universitat Autònoma de Barcelona

Date: 2018
Abstract: Development of RNA interference-based therapies with appropriate therapeutic window remains a challenge for advanced cancers. Because cancer stem cells (CSC) are responsible of sustaining the metastatic spread of the disease to distal organs and the progressive gain of resistance of advanced cancers, new anticancer therapies should be validated specifically for this subpopulation of cells. A new amphihilic-based gene delivery system that combines Pluronic ® F127 micelles with polyplexes spontaneously formed by electrostatic interaction between anionic siRNA and cationic polyethylenimine (PEI) 10K, was designed (PM). Resultant PM gather the requirements for an efficient and safe transport of siRNA in terms of its physicochemical characteristics, internalization capacity, toxicity profile and silencing efficacy. PM were loaded with a siRNA against AKT2, an important oncogene involved in breast cancer tumorigenesis, with a special role in CSC malignancy. Efficacy of siAKT2-PM was validated in CSC isolated from two breast cancer cell lines: MCF-7 and Triple Negative MDA-MB-231 corresponding to an aggressive subtype of breast cancer. In both cases, we observed significant reduction on cell invasion capacity and strong inhibition of mammosphere formation after treatment. These results prompt AKT2 inhibition as a powerful therapeutic target against CSC and pave the way to the appearance of more effective nanomedicine-based gene therapies aimed to prevent CSC-related tumor recurrence.
Grants: Instituto de Salud Carlos III PI14/02079
Rights: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. Creative Commons
Language: Anglès
Document: Article ; recerca ; Versió publicada
Subject: Polymeric micelles ; Pluronic ® ; Gene delivery ; AKT2 ; Cancer stem cells
Published in: Drug Delivery, Vol. 25 (april 2018) , p. 961-972, ISSN 1521-0464

DOI: 10.1080/10717544.2018.1461276
PMID: 29667444


1.9 MB

The record appears in these collections:
Articles > Research articles
Articles > Published articles

 Record created 2020-07-13, last modified 2024-05-22



   Favorit i Compartir